METHODS: All 68 patients were treated with ibandronate during the intermission of chemotherapy. Bone pain, ADL, bone metastasis focus, change of serum Ca2 + level and side effect were observed.
METHODS: All 68 patients were treated with ibandronate during the intermission of chemotherapy. Bone pain, ADL, bone metastasis focus, change of serum Ca2 + level and side effect were observed.